sameAs
A Structural Biology Approach Enables the Development of Antimicrobials Targeting Bacterial Immunophilins1H and 13C nuclear magnetic resonance studies of the sites of protonation in itraconazole and fluconazoleCinnamic Acid Bornyl Ester Derivatives from Valeriana wallichii Exhibit Antileishmanial In Vivo Activity in Leishmania major-Infected BALB/c Mice[How safe was oseltamivir care in the flu pandemic?].Quantitative ¹H NMR analysis of egg yolk, alcohol, and total sugar content in egg liqueurs.Fenton's oxidation: a tool for the investigation of potential drug metabolites.Multivariate analysis of nuclear magnetic resonance data--characterization of critical drug substance quality of gentamicin sulfate.Differentiation of Organically and Conventionally Grown Tomatoes by Chemometric Analysis of Combined Data from Proton Nuclear Magnetic Resonance and Mid-infrared Spectroscopy and Stable Isotope Analysis.Random chemistry as a new tool for the generation of small compound libraries: development of a new acetylcholinesterase inhibitor.Evaluation of amino sugar, low molecular peptide and amino acid impurities of biotechnologically produced amino acids by means of CE.Chiral capillary electrophoresis: facts and fiction on the reproducibility of resolution with randomly substituted cyclodextrins.Random chemistry as a new tool for the generation of small-compound libraries.Laser-induced fluorescence-capillary electrophoresis and fluorescence microplate reader measurement: two methods to quantify the effect of antibiotics.Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecidPopulation pharmacokinetic comparison and pharmacodynamic breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteersEvaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers.Synthesis and opioid receptor affinity of a series of 2, 4-diaryl-substituted 3,7-diazabicylononanones.Identification and control of impurities in streptomycin sulfate by high-performance liquid chromatography coupled with mass detection and corona charged-aerosol detection.Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation.Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.Mechanism of action of the diazabicyclononanone-type kappa-agonists.Semisynthetic analogues of toxiferine I and their pharmacological properties at α7 nAChRs, muscle-type nAChRs, and the allosteric binding site of muscarinic M2 receptors.The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling4-[(2E)-2-(4-Chloro-benzyl-idene)hydrazinyl-idene]-1-methyl-1,4-dihydro-pyridine monohydrate.Nonlinear pharmacokinetics of piperacillin in healthy volunteers--implications for optimal dosage regimensBis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity.Do we need new drugs against human African trypanosomiasis?1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier.Comparable population pharmacokinetics and pharmacodynamic breakpoints of cefpirome in cystic fibrosis patients and healthy volunteers.Matrix-assisted laser desorption/ionization tandem mass spectrometry of N-glycans derivatized with isonicotinic hydrazide and its biotinylated form.Evaluation of enantiomeric purity of magnesium-L-aspartate dihydrate.Ionic liquid versus prodrug strategy to address formulation challenges.Transformation of acidic poorly water soluble drugs into ionic liquids.Profiling a gut microbiota-generated catechin metabolite's fate in human blood cells using a metabolomic approach.Anti-Schistosomal Activity of Cinnamic Acid Esters: Eugenyl and Thymyl Cinnamate Induce Cytoplasmic Vacuoles and Death in Schistosomula of Schistosoma mansoni.Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.Bistacrine derivatives as new potent antimalarials.Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin.Development, synthesis and structure-activity-relationships of inhibitors of the macrophage infectivity potentiator (Mip) proteins of Legionella pneumophila and Burkholderia pseudomallei.
P50
Q27681063-BEE838C2-3CB4-45C5-83A5-088A1B80A1A8Q28372402-DDB5B5B2-2182-4AF9-A9EB-5DA905B0D786Q28550787-4BCCCA18-6F12-446D-90A9-C441B24FCBCAQ30403322-0CA765EE-DD9D-4120-BBE8-610B1A41D0CCQ30929107-5C178771-2F81-45E6-A985-3E303DD6244BQ30996151-40F3C7B4-C022-4848-99CC-094CE49F3FABQ30998760-F4A0EF87-936F-412F-8067-C11D81E0E122Q31004433-68F2111F-7C6D-4EDA-97FD-0B17558B66BAQ31017004-9DFA04F0-2798-4192-942A-0B8B9C127BA1Q32108264-1105DD26-9643-43DF-858A-18CC724BB7B1Q33206528-1AC6D8E9-611B-4ED0-8AE8-754E1CB77FAEQ33255076-7FA1F65A-FFF5-415A-B17C-6554878425A1Q33296866-D4955218-9E85-40AC-B710-F489B2175474Q33558143-0176BD96-32A9-490F-B4F0-307EF81E7F06Q33668223-92A646C8-AB5A-4469-B906-4EA7B1FC1673Q33676387-88E35CC0-9FC5-47C4-BA6F-A56857E17C7CQ33770046-F9F0C0BB-B1BF-49F4-ADF2-2570D6C9FC23Q33920393-10E34961-7D40-4DBC-9EA2-1F7D3A6F348CQ33930082-091EE8CB-DEA7-4CC2-A99D-EAF8B04C4BCBQ34080422-C147837F-BF69-4BEC-92D5-CFD41AD7ADDFQ34178746-5D3989A4-3D5E-4B58-BC63-38F81CB03490Q34187905-A51E53FF-A253-4D6D-89D3-B2096A31C1B3Q34249775-52C1460D-6B35-452B-8242-42DDE2759627Q34297570-12C90DE0-5F8A-48EC-BFB6-9F91D5BD39F9Q34302735-4E2B6DB5-3DC4-4249-9617-2F06E9301545Q34381321-8394E2EA-7AA8-47FF-8103-BA24156274F9Q34404812-A523AE8E-AA10-4E24-B13F-3D7D68C71AEEQ34655561-1F8A1F72-9D18-4035-936C-5F6BB69975DEQ34706209-09A96B93-473A-4A73-971F-AC27F574ABDBQ35005118-AF75EC6E-4D0C-471B-A8E6-672701527B0FQ35197087-81722588-C08A-429A-9DD9-04C7B9742980Q35281930-9897FDF8-02E8-433D-889D-D1FF09449B68Q35532861-B3EEF303-F459-4367-B1C9-453F40F320ECQ35632308-97A590D3-28D6-418E-9FA1-F9244FBC2618Q35646820-67261EFD-005F-40C3-8CCC-2BAFDDF99CCAQ35663977-F6934542-F154-45EA-9A6E-55DCC17D9C63Q35878860-6D8AEB49-21B3-48AD-B40B-516CCE527236Q36055763-6E3AB2A6-13A5-4D02-AA42-17EEEEA2C415Q36094911-A37246D3-C94A-429C-8085-13C5DE505F9BQ36122316-AAB10CE1-2239-4367-A50C-A54143CA2C60
P50
description
deutsche Pharmazeutin und Chem ...... tglied der Universitätsleitung
@de
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Ulrike Holzgrabe
@ast
Ulrike Holzgrabe
@de
Ulrike Holzgrabe
@en
Ulrike Holzgrabe
@es
Ulrike Holzgrabe
@nl
Ulrike Holzgrabe
@sl
type
label
Ulrike Holzgrabe
@ast
Ulrike Holzgrabe
@de
Ulrike Holzgrabe
@en
Ulrike Holzgrabe
@es
Ulrike Holzgrabe
@nl
Ulrike Holzgrabe
@sl
prefLabel
Ulrike Holzgrabe
@ast
Ulrike Holzgrabe
@de
Ulrike Holzgrabe
@en
Ulrike Holzgrabe
@es
Ulrike Holzgrabe
@nl
Ulrike Holzgrabe
@sl
P1006
P214
P227
P244
P1006
P106
P1153
7006635259
P19
P2080
P21
P214
P227
P244
nb99078560
P31
P496
0000-0002-0364-7278
P569
1956-01-25T00:00:00Z
P735
P7859
lccn-nb99078560